NASDAQ:LEXX | World Briefings
Subscribe to World Briefings's newsletter

News Updates

Let's join our newsletter!

Do not worry we don't spam!

Lexaria Bioscience Appoints New CEO as Company Transitions to Focus on Pharmaceutical Industry Collaboration

Business

9 Sep, 2024

Lexaria Bioscience Appoints New CEO as Company Transitions to Focus on Pharmaceutical Industry Collaboration


Lexaria Bioscience Corp. (NASDAQ:LEXX) is embarking on a new era with a renewed focus on pharmaceutical industry collaborations and advancing...

Newsletter
Subscribe to Newsletter

Stay Tuned With Updates